Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The murine Ly49 family: form and function.

A P Makrigiannis1, S K Anderson

  • 1Division of Basic Sciences, SAIC Frederick, National Cancer Institute-FCRDC, MD 21702-1201, USA.

Archivum Immunologiae Et Therapiae Experimentalis
|March 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma.

Neuro-oncology·2025
Same author

Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

Journal of neuro-oncology·2019
Same author

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

Journal of neuro-oncology·2019
Same author

TET2 binds the androgen receptor and loss is associated with prostate cancer.

Oncogene·2016
Same author

Analysis of Ly49 gene transcripts in mature NK cells supports a role for the Pro1 element in gene activation, not gene expression.

Genes and immunity·2016
Same author

Characterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes.

Genes and immunity·2015

Murine natural killer (NK) cells use Ly49 receptors to recognize MHC class I, functionally mimicking human KIRs. Studying Ly49 receptors offers insights into human NK cell regulation and function.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Biology

Background:

  • Natural killer (NK) cell activity is regulated by surface receptors interacting with MHC class I molecules.
  • Murine NK cells employ the Ly49 receptor family, while human NK cells use KIRs.
  • Despite structural differences, Ly49 and KIR families share functional similarities in NK cell regulation.

Purpose of the Study:

  • To review the current understanding of the Ly49 receptor family in mice.
  • To highlight the functional equivalence between murine Ly49 receptors and human KIRs.
  • To underscore the relevance of murine studies for understanding human NK cell function.

Main Methods:

  • Literature review of studies on Ly49 receptors and NK cell function.
  • Comparative analysis of murine Ly49 and human KIR receptor systems.

Related Experiment Videos

  • Examination of signal transduction pathways involved in NK cell activation and inhibition.

    • Main Results:

    • The Ly49 family comprises multiple lectin-related receptors crucial for murine NK cell recognition of MHC class I.
    • Ly49 receptors utilize similar signaling pathways to KIRs for modulating NK cell responses.
    • Evidence suggests Ly49 and KIRs are functional homologs despite distinct evolutionary origins.

    Conclusions:

    • The Ly49 receptor system in mice serves as a valuable model for understanding NK cell immunity.
    • Insights gained from studying Ly49 receptors can inform strategies for manipulating human NK cell activity.
    • Further research into the Ly49 family will enhance our comprehension of NK cell-mediated immune surveillance and disease pathogenesis.